Related Experiment Video
Updated: Jun 13, 2026

09:27
Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
Published on: January 17, 2014
Fluorescent protein-expressing Modified Vaccinia Ankara encoding T7 RNA polymerase
Nathaniel Jackson1, Mahmoud Bayoumi1,2, Himadri Nath1
1Host-pathogen interactions and Disease Intervention and Prevention programs, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Journal of Virology
|June 12, 2026
Summary
We developed fluorescent Modified Vaccinia Ankara-T7 (MVA-T7) viruses for improved recovery of negative-stranded RNA viruses. These fluorescent MVA-T7 viruses enable direct visualization of infection and simplify virus stock management, enhancing reverse genetics efficiency.
Area of Science:
- Virology
- Molecular Biology
- Gene Expression Systems
Background:
- Efficient recovery of negative-stranded RNA viruses relies on bacteriophage T7 RNA polymerase, often supplied by Modified Vaccinia Ankara expressing T7 polymerase (MVA T7).
- Challenges exist in generating virus stocks, monitoring MVA T7 infection, and detecting residual helper virus during recombinant virus rescue.
Purpose of the Study:
- To generate and characterize fluorescent protein-expressing MVA T7 viruses (EGFP and mRFP1) for improved visualization and management in reverse genetics.
- To assess if fluorescent MVA T7 viruses maintain growth kinetics and transgene expression comparable to parental MVA T7.
- To evaluate the utility of fluorescent MVA T7 viruses in facilitating recombinant virus rescue and detecting helper virus carryover.
Main Methods:
- Generation of MVA T7 viruses expressing enhanced green fluorescent protein (EGFP) or monomeric red fluorescent protein 1 (mRFP1).
- Characterization of fluorescent MVA T7 viruses for plaque morphology, growth kinetics, and transgene expression.
- Assessment of transient protein expression and rescue of recombinant vesicular stomatitis virus (rVSV) using fluorescent MVA T7 viruses.
- Evaluation of helper virus detection during rVSV recovery and amplification.
Main Results:
- Fluorescent MVA T7 viruses (EGFP and mRFP1) exhibited comparable plaque morphology, growth kinetics, and transgene expression to parental MVA T7.
- Fluorescent MVA T7 viruses efficiently supported foreign gene expression and rVSV rescue.
- Direct visualization of MVA T7 infection was enabled by fluorescent proteins.
- Fluorescent MVA T7 viruses facilitated stock generation, titration, and detection of helper virus carryover.
Conclusions:
- EGFP- and mRFP1-expressing MVA T7 viruses are practical tools for monitoring T7-driven rescue of recombinant RNA viruses.
- These fluorescent viruses improve the efficiency, reproducibility, and quality control of reverse genetics systems.
- They simplify stock management and enable rapid identification of helper virus contamination, enhancing viral rescue and amplification processes.

